Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Bioriginal Europe/Asia Announces 3 New Appointments
Company appoints Mr. Martin Hettema, MSc., Area Sales Manager-Asia, Mrs. Hanneke Schleicher QESH Manager, and Mr. Joan de Jong is the new European Operations Manager; All three will be based in Bioriginal’s Netherlands office.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Nutri Pharma Patent upheld by European Patent Office
European Patent Office upholds Patent No. 0902624 against opposition of Solae LLC.
- Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005
Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005.
- Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005
Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005.
- Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005
Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005.
- Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005
Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005.
- Chr. Hansen Showcases "Out of the Ordinary" Flavors At Upcoming SNAXPO 2005
Company will showcase different flavored snack concepts each day at SNAXPO 2005, the 68th Snack Food Association's Annual Exhibit and Conference, to be held in Hollywood, Florida on March 12 - 15, 2005.
- BioGaia AB Presents Year-end Report for 2004
Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003.
- BioGaia AB Presents Year-end Report for 2004
Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003.
- BioGaia AB Presents Year-end Report for 2004
Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003.
- BioGaia AB Presents Year-end Report for 2004
Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003.
- BioGaia AB Presents Year-end Report for 2004
Company reports sales of SEK 40.4 million (USD $5.8 million) compared with SEK 35.6 million prior year, with gross profit of SEK 24.8 million (USD $3.56 mllion) compared with SEK 24.6 million previous year as margins fell from 69% to 61%. Net income was SEK(-23.2 million)(USD -$3.33 million) for 2004 versus SEK (-13.0 million) (USD-$1.87 million) for 2003.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- Campina Investing in Whey Processing and Food Ingredient Operations
Company is investing EUR 57 million into its whey processing and food ingredient facilities in Veghel, The Netherlands with the intention of producing new and unique whey based ingredients with the first commercial products expected during Q3 2006; DMV facilities in Uitgeest - The Netherlands to be closed due to restructuring.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- UK: Vitamin and Mineral Dossiers Submitted
Agency has received 14 dossiers so far, and list will be updated as additional dossiers are submitted.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Daily Supplement May Boost Birthweight of Babies In The Developing World
Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- U.K. Food Standards Agency Approves Continued Sale of Chromax® Chromium Picolinate
Company announces filing of dossier for European-wide approval of Chromax; UK Food Standards Agency has granted 'derogation' for Chromax® chromium picolinate in England, Scotland, Wales and Northern Ireland.
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Appointment of New Food Standards Agency (UK) Chair
Dame Deirdre Hutton - currently Deputy Chair of the Financial Services Authority, a member of the Better Regulation Task Force, Chair of the National Consumer Council and Deputy Chair of the European Food Safety Authority - has been appointed Chair of the Food Standards Agency (FSA).
- Forbes Medi-Tech Announces Product Launch with Kesko of Finland
Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
- Forbes Medi-Tech Announces Product Launch with Kesko of Finland
Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
- Forbes Medi-Tech Announces Product Launch with Kesko of Finland
Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
- Forbes Medi-Tech Announces Product Launch with Kesko of Finland
Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
- Forbes Medi-Tech Announces Product Launch with Kesko of Finland
Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
~Approval Creates New Opportunities for Cholesterol-Lowering Ingredient in Europe~
Vancouver, BC -- Forbes Medi-Tech Inc. (TSX: FMI; NASDAQ: FMTI) announced today that the Company received an opinion of substantial equivalence from European regulatory authorities allowing Forbes to market its cholesterol-lowering ingredient, Reducol(tm), in a variety of approved food groups including: yellow fat spreads (margarine), fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad dressings. The substantial equivalence notification follows the recent approval for the use of Reducol(tm) in milk-based products. With regulatory approvals in place and the recently announced expansion of the Company's 50-50 manufacturing joint-venture facility, Forbes is in a favorable position to capitalize on EU consumers' preference for non-GMO foods.
"Our sales opportunities have increased significantly with the approval of Reducol(tm) in these key food groups," said President and CEO, Charles Butt. "I am very encouraged by the level of enthusiasm of our European partners as they prepare for Reducol(tm) product launches in the coming months."
About Reducol(tm)
Reducol(tm) is a clinically proven ingredient to help lower LDL (bad) cholesterol levels safely and naturally. It is a unique blend of naturally occurring compounds found in plants known as phytosterols and phytostanols. Reducol(tm) is produced by the Phyto-Source joint venture manufacturing facility in Pasadena, Texas, a 50-50 joint venture currently representing the largest approved source of food grade wood sterols in the world. Additional information on Reducol(tm) can be found at www.reducol.com
About Forbes Medi-Tech Inc.
Forbes Medi-Tech Inc. is a biopharmaceutical company dedicated to the research, development and commercialization of innovative prescription pharmaceutical and nutraceutical products derived from by-products of the forestry industry and other natural sources for the prevention and treatment of cardiovascular and related diseases. The Company's scientific platform is based on core sterol technology. Forbes has developed cholesterol-lowering agents for use in pharmaceutical compounds, functional foods and dietary supplements.
For more information, please contact:
NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. This News Release contains forward-looking statements regarding new sales opportunities for Reducol(tm) in Europe and future product launches. Forward looking statements can be identified by the use of forward-looking terminology such as "opportunties", "prepare for", "coming months", "to capitalize" or any other variations thereon or comparable terminology referring to future dates, events or results. Forward-looking statements are statements about the future and are inherently uncertain, and the Company's actual results could differ materially from those anticipated in those forward-looking statements as a result of numerous factors, including without limitation; uncertainty of the size and existence of a market opportunity for the Company's and its customers' products; uncertainty whether planned product launches will occur as planned; uncertainty regarding market acceptance of the Company's and its customers' products; the need for performance by the Company's customers; product liability and insurance risks; the Company's dependency on its manufacturing joint venture partner; marketing/manufacturing and partnership/strategic alliance risks; the effect of competition; exchange rate fluctuations; the Company's need for additional future capital, which may not be available in a timely manner or at all; intellectual property risks; environmental risks; as well as a description of other risks and uncertainties affecting the Company and its business, as contained in news releases and filings with the United States Securities and Exchange Commission and Canadian Securities Regulatory Authorities, any of which could cause actual results to vary materially from current results or the Company's anticipated future results. Forward-looking statements are based on the beliefs, opinions and expectations of the Company's management at the time they are made, and the Company does not assume any obligation to update its forward-looking statement if those beliefs, opinions or expectations, or other circumstances should change.
|